Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study. J of Skin [Internet]. 2025 Jul. 23 [cited 2025 Nov. 16];9(4):s582. Available from: https://skin.dermsquared.com/skin/article/view/3495